BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu D, Zeng X, Ding Z, Lv F, Mehta JL, Wang X. Adverse Cardiovascular Effects of Anti-COVID-19 Drugs. Front Pharmacol 2021;12:699949. [PMID: 34512335 DOI: 10.3389/fphar.2021.699949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Abdel Moniem A, Radwan MA, Yousef AI. COVID-19 and cardiovascular disease: Manifestations, pathophysiology, vaccination, and long-term implication. Current Medical Research and Opinion. [DOI: 10.1080/03007995.2022.2078081] [Reference Citation Analysis]
2 Aghamiri SS, Amin R, Helikar T. Recent applications of quantitative systems pharmacology and machine learning models across diseases. J Pharmacokinet Pharmacodyn 2021. [PMID: 34671863 DOI: 10.1007/s10928-021-09790-9] [Reference Citation Analysis]
3 Ahmadi I, Estabraghnia Babaki H, Maleki M, Jarineshin H, Kaffashian MR, Hassaniazad M, Kenarkoohi A, Ghanbarnejad A, Falahi S, Kazemi Jahromi M, Ghaneialvar H, Sohrabipour S, Borretta G. Changes in Physiological Levels of Cortisol and Adrenocorticotropic Hormone upon Hospitalization Can Predict SARS-CoV-2 Mortality: A Cohort Study. International Journal of Endocrinology 2022;2022:1-7. [DOI: 10.1155/2022/4280691] [Reference Citation Analysis]
4 Chiu MN, Bhardwaj M, Sah SP. Safety profile of COVID-19 drugs in a real clinical setting. Eur J Clin Pharmacol 2022. [PMID: 35088108 DOI: 10.1007/s00228-021-03270-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]